title: Cost of Treating Acute Promyelocytic Leukemia (APL) Patients in Italy.
authors.affiliation: Optum, Waltham, MA, USA.
authors.forename: M M
authors.initials: MM
authors.lastname: Kruse
authors.affiliation: Optum, Waltham, MA, USA.
authors.forename: R
authors.initials: R
authors.lastname: Wildner
authors.affiliation: Teva Pharmaceutical, 19355, PA, USA.
authors.forename: G
authors.initials: G
authors.lastname: Barnes
authors.affiliation: OptumInsight, Uxbridge, Middlesex, UK.
authors.forename: M
authors.initials: M
authors.lastname: Martin
authors.affiliation: Teva Pharmaceutical, Ehrenkirchen, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Mueller
authors.affiliation: University Tor Vergata, Rome, PA, USA.
authors.forename: F
authors.initials: F
authors.lastname: Lo Coco
authors.affiliation: TEVA Pharmaceuticals Europe, Amsterdam, The Netherlands.
authors.forename: S
authors.initials: S
authors.lastname: Leyman
authors.affiliation: Teva Pharmaceutical, 19355, PA, USA.
authors.forename: A
authors.initials: A
authors.lastname: Pathak